Sean A. McCarthy, CEO: CytomX Therapeutics CTMX Sell · Filed 25/06/17

Trade details

Type: Insider sale
Amount: $149,324.59
Shares · price: 55,511 sh · $2.69 a share
Held after: 1,089,684 sh
Stock: CytomX Therapeutics CTMX
Person: Sean A. McCarthyCEO
Trade date: 25/06/16
Filed: 25/06/17
Days to filing: 1 days

Sold 4.8% of holdings

Share of holding sold: 4.8%

CytomX Therapeutics trades, last 26 weeks

What else happened in CytomX Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/17~25/07/16

Sean A. McCarthy's recent trades

Sean A. McCarthyCEO
Sell10b5-1 planCytomX Therapeutics
Sell10b5-1 plan
CytomX Therapeutics
CTMX
$763.8K
118,969 sh
$763.8K
Filed 03/19
Traded 03/17
Sean A. McCarthyCEO
Sell10b5-1 planCytomX Therapeutics
Sell10b5-1 plan
CytomX Therapeutics
CTMX
$462.1K
101,793 sh
$462.1K
Filed 25/11/10
Traded 25/11/06
Sean A. McCarthyCEO
Planned sale10b5-1 planCytomX Therapeutics
Planned sale10b5-1 plan
CytomX Therapeutics
CTMX
$461.9K
101,793 sh
$461.9K
Filed 25/11/06
Traded 25/11/06
Sean A. McCarthyCEO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$22.6K
37,656 sh
$22.6K
Filed 25/03/20
Traded 25/03/18
Sean A. McCarthyCEO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$17.1K
13,898 sh
$17.1K
Filed 24/08/22
Traded 24/08/20